Results from ongoing study suggest the major role of Celartics' Cov-DCVax in preventing viral infection of COVID-19 and in controlling progression of the virus-associated diseasesBeijing, May 22, 2020, Celartics Biopharma announced today the filing of a patent application covering a novel dendritic cell (DC)-based vaccine, Cov-DCVax, to fight viral infection of COVID-19. The results, led by Celart
05-22
04-18
04-18
04-10
03-21
Stabilizing Foreign Trade and Expanding Consumption: Guangzhou Baima Border Trade Supply Chain Matchmaking Conference Opens New Trade Channels
Tarif AS: Lawatan Tengku Zafrul ke Washington diyakini membuahkan hasil
Daya tahan pertumbuhan ekonomi perkukuh kedudukan negara
MGA galak pembelian barang kemas sebagai pelaburan jangka panjang
SEDANIA Innovator optimis permintaan barangan pengguna terus kukuh
Pelabur AS kekal komited, perkukuh aspirasi Malaysia jadi hab semikonduktor global
©hak cipta2009-2020 Forum Teknologi Malaysia Timur